Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Home
Tags
Hepatitis C
Tag: Hepatitis C
Blog
Strong call for transparency on medicine prices, cost of R&D at WHO Fair Pricing Forum
Ellen 't Hoen
-
April 19, 2019
0
Blog
2018 Round-up of Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 26, 2018
0
Blog
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
0
Blog
Wrapping Up 2017 – some noteworthy medicines law and policy events.
Ellen 't Hoen
-
December 31, 2017
0
Blog
Medicines Excitement in the Netherlands – New Health Minister announces firm action on “absurd” medicines pricing and gets the European Medicines Agency.
Ellen 't Hoen
-
November 24, 2017
0
Blog
The Italian Exception – A personalised approach to accessing high-priced patented medicines
Ellen 't Hoen
-
May 5, 2017
0
Blog
High medicines prices in Europe – do not Brexit the people
Ellen 't Hoen
-
July 21, 2016
0
Blog
Gilead’s sofosbuvir patent in India – options for global access to new hepatitis C medicines
Ellen 't Hoen
-
May 26, 2016
0
